These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 14600076

  • 21. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS, Chen WC, Bai X, Wang YD.
    J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
    [Abstract] [Full Text] [Related]

  • 22. 15-Deoxy-delta12,14-PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product?
    Powell WS.
    J Clin Invest; 2003 Sep; 112(6):828-30. PubMed ID: 12975467
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R, Iñiguez MA, Fresno M.
    Cancer Res; 2004 Aug 01; 64(15):5162-71. PubMed ID: 15289320
    [Abstract] [Full Text] [Related]

  • 24. Attenuation of IFN-γ-induced B7-H1 expression by 15-deoxy-delta(12,14)-prostaglandin J2 via downregulation of the Jak/STAT/IRF-1 signaling pathway.
    Seo SK, Seo DI, Park WS, Jung WK, Lee DS, Park SG, Choi JS, Kang MS, Choi YH, Choi I, Yu BC, Choi IW.
    Life Sci; 2014 Sep 01; 112(1-2):82-9. PubMed ID: 25072357
    [Abstract] [Full Text] [Related]

  • 25. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
    Kaplan J, Cook JA, O'Connor M, Zingarelli B.
    Shock; 2007 Dec 01; 28(6):722-726. PubMed ID: 17621259
    [Abstract] [Full Text] [Related]

  • 26. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
    Morosetti R, Servidei T, Mirabella M, Rutella S, Mangiola A, Maira G, Mastrangelo R, Koeffler HP.
    Int J Oncol; 2004 Aug 01; 25(2):493-502. PubMed ID: 15254749
    [Abstract] [Full Text] [Related]

  • 27. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
    Liu J, Xia Q, Zhang Q, Li H, Zhang J, Li A, Xiu R.
    Shock; 2009 Sep 01; 32(3):317-24. PubMed ID: 19174742
    [Abstract] [Full Text] [Related]

  • 28. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma).
    Patel KM, Wright KL, Whittaker P, Chakravarty P, Watson ML, Ward SG.
    Cell Signal; 2005 Sep 01; 17(9):1098-110. PubMed ID: 15993751
    [Abstract] [Full Text] [Related]

  • 29. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
    Zhang J, Fang NY, Gao PJ, Wu LY, Han WQ, Guo SJ, Shen WL, Zhu DL.
    Clin Exp Pharmacol Physiol; 2008 Jan 01; 35(1):72-7. PubMed ID: 18047631
    [Abstract] [Full Text] [Related]

  • 30. Peroxisome proliferator-activated receptor-gamma-independent repression of collagenase gene expression by 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and prostaglandin 15-deoxy-delta(12,14) J2: a role for Smad signaling.
    Mix KS, Coon CI, Rosen ED, Suh N, Sporn MB, Brinckerhoff CE.
    Mol Pharmacol; 2004 Feb 01; 65(2):309-18. PubMed ID: 14742672
    [Abstract] [Full Text] [Related]

  • 31. 15-deoxy-Delta12,14-prostaglandin J2 induces renal epithelial cell death through NF-kappaB-dependent and MAPK-independent mechanism.
    Kang DS, Kwon CH, Park JY, Kim JH, Woo JS, Jung JS, Kim YK.
    Toxicol Appl Pharmacol; 2006 Nov 01; 216(3):426-35. PubMed ID: 16890972
    [Abstract] [Full Text] [Related]

  • 32. PGJ2 inhibition of LPS-induced inflammatory mediator expression from rat alveolar macrophages.
    Porter DW, Wolfarth M, Young SH, Rao MK, Meighan T, Barger M, Andrew ME, Huffman LJ.
    J Toxicol Environ Health A; 2007 Dec 01; 70(23):1967-76. PubMed ID: 17966068
    [Abstract] [Full Text] [Related]

  • 33. Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway.
    Park KS, Lee RD, Kang SK, Han SY, Park KL, Yang KH, Song YS, Park HJ, Lee YM, Yun YP, Oh KW, Kim DJ, Yun YW, Hwang SJ, Lee SE, Hong JT.
    Exp Cell Res; 2004 Jul 15; 297(2):424-33. PubMed ID: 15212945
    [Abstract] [Full Text] [Related]

  • 34. Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia.
    Zang C, Liu H, Posch MG, Waechter M, Facklam M, Fenner MH, Ruthardt M, Possinger K, Phillip Koeffler H, Elstner E.
    Leuk Res; 2004 Apr 15; 28(4):387-97. PubMed ID: 15109539
    [Abstract] [Full Text] [Related]

  • 35. STAT5 activation by human GH protects insulin-producing cells against interleukin-1beta, interferon-gamma and tumour necrosis factor-alpha-induced apoptosis independent of nitric oxide production.
    Jensen J, Galsgaard ED, Karlsen AE, Lee YC, Nielsen JH.
    J Endocrinol; 2005 Oct 15; 187(1):25-36. PubMed ID: 16214938
    [Abstract] [Full Text] [Related]

  • 36. Tumor necrosis factor alpha-induced pancreatic beta-cell insulin resistance is mediated by nitric oxide and prevented by 15-deoxy-Delta12,14-prostaglandin J2 and aminoguanidine. A role for peroxisome proliferator-activated receptor gamma activation and inos expression.
    Kwon G, Xu G, Marshall CA, McDaniel ML.
    J Biol Chem; 1999 Jun 25; 274(26):18702-8. PubMed ID: 10373483
    [Abstract] [Full Text] [Related]

  • 37. Differential effects of 15-deoxy-delta(12,14)-prostaglandin J2 and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation.
    Guyton K, Bond R, Reilly C, Gilkeson G, Halushka P, Cook J.
    J Leukoc Biol; 2001 Apr 25; 69(4):631-8. PubMed ID: 11310850
    [Abstract] [Full Text] [Related]

  • 38. 15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats.
    Zhao X, Zhang Y, Strong R, Grotta JC, Aronowski J.
    J Cereb Blood Flow Metab; 2006 Jun 25; 26(6):811-20. PubMed ID: 16208315
    [Abstract] [Full Text] [Related]

  • 39. THE PPARgamma ligand 15d-PGJ2 modulates macrophage activation after injury in a murine trauma model.
    Monroy MA, Opperman KK, Pucciarelli M, Yerrum S, Berg DA, Daly JM.
    Shock; 2007 Aug 25; 28(2):186-91. PubMed ID: 17510607
    [Abstract] [Full Text] [Related]

  • 40. 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways.
    Boyault S, Simonin MA, Bianchi A, Compe E, Liagre B, Mainard D, Bécuwe P, Dauça M, Netter P, Terlain B, Bordji K.
    FEBS Lett; 2001 Jul 13; 501(1):24-30. PubMed ID: 11457450
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.